Exploration of Targeted Anti-tumor Therapy

Open Access Original Article

Transurethral laser ablation using 980-nm diode laser for recurrent non-muscle invasive bladder cancer

Hideo Fukuhara ... Keiji Inoue

Published: July 28, 2026 Explor Target Antitumor Ther. 2026;7:1002386

DOI: https://doi.org/10.37349/etat.2026.1002386

This article belongs to the special issue Emerging Innovation in Surgical and Medical Approaches on the Horizon for Urogenital Malignancies

Full Text PDF

51 6 0

Open Access Short Communication

FGFR3 gene alteration and protein expression in upper urinary tract carcinoma: unsuitability of ureteroscopic biopsy specimens for FGFR3 RNA testing

Makito Miyake ... Kiyohide Fujimoto

Published: July 28, 2026 Explor Target Antitumor Ther. 2026;7:1002385

DOI: https://doi.org/10.37349/etat.2026.1002385

This article belongs to the special issue Emerging Innovation in Surgical and Medical Approaches on the Horizon for Urogenital Malignancies

Full Text PDF

49 7 0

Open Access Review

Can we now save the neck of OSCC T1–T2 patients? A narrative review of whether experimental techniques are on the way to clinical application

Vincenzo Cuccurullo ... Giuseppe Lucio Cascini

Published: July 23, 2026 Explor Target Antitumor Ther. 2026;7:1002384

DOI: https://doi.org/10.37349/etat.2026.1002384

Full Text PDF

118 14 0

Open Access Review

Reactive oxygen species (ROS) in cancer: from redox signaling and metabolic plasticity to therapeutic vulnerabilities

Taslim Uddin ... Shubhro Saha

Published: July 23, 2026 Explor Target Antitumor Ther. 2026;7:1002383

DOI: https://doi.org/10.37349/etat.2026.1002383

Full Text PDF

422 20 0

Open Access Original Article

L3MBTL4 methylation is a sensitive marker of DNA-PK inhibitor in pancreatic cancer

Yuanxin Yao ... Mingzhou Guo

Published: July 23, 2026 Explor Target Antitumor Ther. 2026;7:1002382

DOI: https://doi.org/10.37349/etat.2026.1002382

This article belongs to the special issue Cancer Epigenetics: Implications for Novel Therapeutic Strategies

Full Text PDF

140 11 0

Open Access Review

Predictive biomarkers for immunotherapy response in endometrial cancer: current insights and future directions

Giuliana Pavone ... Ilaria Colombo

Published: July 23, 2026 Explor Target Antitumor Ther. 2026;7:1002381

DOI: https://doi.org/10.37349/etat.2026.1002381

Full Text PDF

280 8 0

Open Access Original Article

Mechanistic study of antisense long non-coding RNA STEAP3-AS1 in breast cancer

Jinquan Sun ... Guoshuang Shen

Published: July 23, 2026 Explor Target Antitumor Ther. 2026;7:1002380

DOI: https://doi.org/10.37349/etat.2026.1002380

This article belongs to the special issue Breaking Boundaries in Breast Cancer Care: Emerging Controversies and Innovation in Surgical and Medical Approaches

Full Text PDF

160 6 0

Open Access Original Article

Oncologic outcome and safety profile of first-line enfortumab vedotin plus pembrolizumab vs. conventional chemotherapy in advanced urothelial cancer

Makito Miyake ... on behalf of the Nara Urological Research Treatment Group

Published: July 06, 2026 Explor Target Antitumor Ther. 2026;7:1002379

DOI: https://doi.org/10.37349/etat.2026.1002379

This article belongs to the special issue Emerging Innovation in Surgical and Medical Approaches on the Horizon for Urogenital Malignancies

Full Text PDF

625 44 0

Open Access Review

Why precision oncology works: lessons from gastrointestinal stromal tumours

Si Ying Adelina Ho ... Vishal G Shelat

Published: July 06, 2026 Explor Target Antitumor Ther. 2026;7:1002378

DOI: https://doi.org/10.37349/etat.2026.1002378

This article belongs to the special issue Precision Oncology: Molecular Classification, Efficacy Prediction, and Treatment Decision-Making

Full Text PDF

531 18 0

Open Access Review

More than alternative estrogen receptors: the emerging role of GPER-1 and ERα36 in breast cancer

Luis Molina Calistro ... Yennyfer Arancibia

Published: July 06, 2026 Explor Target Antitumor Ther. 2026;7:1002377

DOI: https://doi.org/10.37349/etat.2026.1002377

This article belongs to the special issue Breaking Boundaries in Breast Cancer Care: Emerging Controversies and Innovation in Surgical and Medical Approaches

Full Text PDF

833 27 0

Open Access Systematic Review

Impact of smoking on subtypes and molecular profile of breast cancer: a systematic review

Georgia Ntella ... Athina Diamanti

Published: June 16, 2026 Explor Target Antitumor Ther. 2026;7:1002376

DOI: https://doi.org/10.37349/etat.2026.1002376

Full Text PDF

557 25 0

Open Access Review

ESR1 mutations in ER-positive breast cancer: from endocrine resistance to ctDNA-guided therapeutic interception

Thais Martinez ... Hisham F. Bahmad

Published: May 26, 2026 Explor Target Antitumor Ther. 2026;7:1002375

DOI: https://doi.org/10.37349/etat.2026.1002375

This article belongs to the special issue Breaking Boundaries in Breast Cancer Care: Emerging Controversies and Innovation in Surgical and Medical Approaches

Full Text PDF

2993 83 0

Open Access Review

The evolution of chemotherapy in brain tumors: from historical milestones to precision medicine in glioblastoma

Alessia Ciafarone, Paola Palumbo

Published: May 21, 2026 Explor Target Antitumor Ther. 2026;7:1002374

DOI: https://doi.org/10.37349/etat.2026.1002374

This article belongs to the special issue Novel Precision Medicine Approaches to Brain Tumors (Primary and Metastatic)

Full Text PDF

1333 38 1

Open Access Review

RNA therapeutic targeting of recalcitrant and rare cancers

Afeez Adekunle Ishola ... Bashir Lawal

Published: May 21, 2026 Explor Target Antitumor Ther. 2026;7:1002373

DOI: https://doi.org/10.37349/etat.2026.1002373

Full Text PDF

875 21 0

Open Access Review

Triple-negative breast cancer: current understanding and future perspectives

Alhasan Alobaidi, Vikrant Rai

Published: May 14, 2026 Explor Target Antitumor Ther. 2026;7:1002372

DOI: https://doi.org/10.37349/etat.2026.1002372

Full Text PDF

3052 51 1

Open Access Original Article

Oligometastatic versus polymetastatic colon cancer: functional and genomic determinants of divergent metastatic trajectories

Roberto Sirica ... Alessandro Ottaiano

Published: May 13, 2026 Explor Target Antitumor Ther. 2026;7:1002371

DOI: https://doi.org/10.37349/etat.2026.1002371

Full Text PDF

808 24 0

Open Access Mini Review

The evolving landscape of first-line and subsequent therapies in EGFR-mutated NSCLC: efficacy, resistance, and tolerability

Carminia Maria Della Corte ... Floriana Morgillo

Published: April 27, 2026 Explor Target Antitumor Ther. 2026;7:1002370

DOI: https://doi.org/10.37349/etat.2026.1002370

Full Text PDF

3912 62 0

Open Access Commentary

FDA 2025 Cancer Drug Approvals: targeted therapy dominates

Jan Trøst Jørgensen

Published: April 27, 2026 Explor Target Antitumor Ther. 2026;7:1002369

DOI: https://doi.org/10.37349/etat.2026.1002369

This article belongs to the special issue Precision Oncology: Molecular Classification, Efficacy Prediction, and Treatment Decision-Making

Full Text PDF

11414 63 0

Open Access Systematic Review

The evolving role of targeted radioligand therapy in small cell and non-small cell lung cancer: a systematic review

Serin Moghrabi ... Akram Al-Ibraheem

Published: April 27, 2026 Explor Target Antitumor Ther. 2026;7:1002368

DOI: https://doi.org/10.37349/etat.2026.1002368

Full Text PDF

2088 36 0

Open Access Case Report

Solitary fibrous tumor of the lung: diagnostic challenges and surgical management

Vasileios Leivaditis ... Manfred Dahm

Published: April 21, 2026 Explor Target Antitumor Ther. 2026;7:1002367

DOI: https://doi.org/10.37349/etat.2026.1002367

Full Text PDF

992 18 0